Monday, January 7, 2013
Illumina Buys Verinata Health
San Diego-based life sciences equipment firm Illumina said over the weekend that it is in an agreement to acquire Verinata Health, a provider of non-invasive testing for fetal chromosomal abnormalities. Illumnina said it would pay $350M plus up to $100M in milestone payments for Verinata. Verinata's tests are used for prenatal testing. Illumina was advised by Bank of America Merrill Lynch and Covington & Burling LLP in the deal. Verinata was venture backed by Alloy Ventures, Mohr Davidow Ventures, and Sutter Hill Ventures.
Get More SocalTech Data
Try our two week free trial to find new tech customers, find high tech startups and jobs, find venture funding, and more!Learn More